483 Document: Boehringer Ingelheim Pharma Gmbh & Co Kg, May 4, 2018

FDANews 483 Boehringer Ingelheim Pharma Gmbh & Co Kg May 4 2018 top
Christopher S. Keating FDA Investigator

On May 04, 2018, the FDA inspected Boehringer Ingelheim Pharma Gmbh & Co Kg's Ingelheim am Rhein site. Explore the inspectional observations.